Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Sleep, Mood, and Behavior Study [NA]
A completed clinical trial update from the University of Pittsburgh reports on sleep, mood, and behavior in children with anxiety disorders,…
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder [NA]
A completed clinical trial evaluated transcranial magnetic stimulation for generalized anxiety disorder. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety Disorder [NA]
This clinical trial update summarizes a completed study evaluating Motivational Interviewing and Cognitive Behavioral Therapy for Generalize…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels [Phase 1]
A Phase 1 clinical trial evaluated whether gastric bypass surgery affects blood levels of the antidepressant venlafaxine ER.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: rTMS Treatment in Patients With General Anxiety Disorder [NA]
A completed clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for generalized anxiety disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Microtuning a Bonafide Treatment for GAD Patients - A Randomized Controlled Trial. [Phase 4]
A Phase 4 randomized trial evaluating a behavioral/intervention approach for generalized anxiety disorder, using dyadic peer tutoring and ad…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020) [Phase 2]
A Phase 2 study (0777-020) evaluated MK0777 in outpatients with generalized anxiety disorder. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026) [Phase 2]
A Phase 2 trial comparing GEM at 1.5 mg twice daily and 4.5 mg twice daily to lorazepam for generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019) [Phase 2]
Phase 2 trial of the MK0777 Gel Extrusion Module for generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Treatment of Patients With Anxiety Disorder (0777-022) [Phase 2]
Phase 2 trial for Generalized Anxiety Disorder sponsored by Merck Sharp & Dohme LLC has completed. The update does not include efficacy or s…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder [Phase 2, Phase 3]
Clinical trial update reporting a completed Phase 2/Phase 3 study of pexacerfont (BMS-562086) in outpatients with generalized anxiety disord…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects [Phase 2]
A Phase 2 proof-of-concept efficacy and safety study of eszopiclone (SEP-225441) for Generalized Anxiety Disorder has completed, with result…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care [NA]
This completed clinical trial evaluated cognitive behavioral therapy for generalized anxiety disorder in older adults in a primary care sett…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder [Phase 3]
Phase 3 relapse-prevention study of vortioxetine (Lu AA21004) in generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
A completed clinical trial examined brain markers in youth with anxiety disorders and the effects of SSRI treatment and cognitive-behavioral…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Randomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patients [NA]
Randomized, placebo-controlled study evaluated whether lavender aromatherapy reduces preoperative anxiety in women undergoing breast surgery…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder [Phase 2]
This clinical trial update reports completion of a Phase 2 study evaluating Sensoril for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism [NA]
A completed clinical trial evaluated cognitive behavioral therapy for anxiety disorders in adolescents with autism, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Acamprosate in Alcoholics With Comorbid Anxiety or Depression [Phase 4]
Phase 4 study evaluating acamprosate in individuals with alcohol use disorder and coexisting anxiety or depressive disorders; results have b…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Psychotherapy of Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating psychotherapy for generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines [Phase 4]
Open-label Phase 4 pilot trial evaluating substituting quetiapine for benzodiazepines in major depressive disorder and generalized anxiety d…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder [Phase 3]
A phase 3 open-label pilot trial evaluating memantine as augmentation therapy for generalized anxiety disorder and social anxiety disorder, …
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Experimental Medication For the Treatment of Generalized Anxiety Disorder [Phase 3]
A Phase 3 clinical trial evaluating an experimental medication for generalized anxiety disorder has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients [Phase 4]
Phase 4 clinical trial evaluating a collaborative care program to improve treatment of depression and anxiety disorders in patients with hea…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)
This completed clinical trial investigated locating regions of interest in generalized anxiety disorder using functional MRI.